However, PEA administration could obviously attenuate the expression of both ACC1 and CD36, suggesting that the anti-steatosis effect of PEA is partly dependent on the inhibition of ACC1-mediated lipogenesis and CD36-mediated fatty acids uptake. The gene discussed is ACACA; the disease is steatosis.